4.7 Article

MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth

期刊

CANCER LETTERS
卷 333, 期 2, 页码 159-169

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2013.01.028

关键词

Angiogenesis; miR-503; FGF2; VEGFA; Methylation

类别

资金

  1. National Basic Research (973) Program [2013CB0531101]
  2. State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB16]
  3. Fundamental Research Funds for the Central Universities [2010MS015]
  4. Key Academic Program Leader Award of Wuhan City [200951830560]

向作者/读者索取更多资源

FGF2 and VEGFA are the two most potent angiogenic factors. Here we report that miR-503 can simultaneously down-regulate FGF2 and VEGFA. The expression of miR-503 is repressed in HCC cells and primary tumors due to a potential epigenetic mechanism. Overexpression of miR-503 reduced tumor angiogenesis in vitro and in vivo. We also found that miR-503 expression was down-regulated by hypoxia through HIFI or. These results identify a miRNA that targets both FGF2 and VEGFA in cancers, demonstrate the anti-angiogenesis role of miR-503 in tumorigenesis, and provide a novel mechanism for hypoxia-induced FGF2 and VEGFA through HIFI et-mediated inhibition of miR-503. Published by Elsevier Ireland Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据